Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...
In HIV-positive MSM, pain severity was significantly associated with pain management experiences and unhealthy alcohol use.
Clinical Trials Arena on MSN2d
Tris Pharma eyes approval after pain drug triumphs in second Phase III trialThe company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
PCRX-201 became part of Pacira's portfolio in 2021, but was originally developed at Baylor and then by GQ Bio Therapeutics, ...
A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.
Chronic pain treatment benefits from a holistic approach that integrates physical therapy and behavioral health.
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
To develop an ML model for predicting therapy dropout in chronic pain patients treated ... integrating ML and pharmacogenetics can drive precision medicine in chronic pain management, advancing ...
Severe pain may require prescription medication, physical therapy, or other interventions ... With early and effective management, most people can maintain a high quality of life and continue ...
A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ... and should not be injected. This therapy is available by prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback